Dan-qin P. Sun

Wuxi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study.

Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study.

Journal: MedComm

Published: March 12, 2025

Oxidized-LDL aggravates renal injury via tubular cuproptosis.

Oxidized-LDL aggravates renal injury via tubular cuproptosis.

Journal: Cellular signalling

Published: February 02, 2025

Liver fibrosis progression analyzed with AI predicts renal decline.

Liver fibrosis progression analyzed with AI predicts renal decline.

Journal: JHEP reports : innovation in hepatology

Published: October 16, 2024

Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children.

Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children.

Journal: Frontiers in endocrinology

Published: October 02, 2024

Bioactive metabolites: A clue to the link between MASLD and CKD?

Bioactive metabolites: A clue to the link between MASLD and CKD?

Journal: Clinical and molecular hepatology

Published: September 09, 2024

Associations between skeletal muscle strength and chronic kidney disease in patients with MASLD.

Associations between skeletal muscle strength and chronic kidney disease in patients with MASLD.

Journal: Communications medicine

Published: June 07, 2024

A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.

A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.

Journal: Hepatology international

Published: April 10, 2024

MAFLD as part of systemic metabolic dysregulation.

MAFLD as part of systemic metabolic dysregulation.

Journal: Hepatology international

Published: December 22, 2023

Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.

Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 23, 2023

Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling.

Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling.

Journal: Molecular metabolism

Published: September 19, 2023

Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis.

Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis.

Journal: eGastroenterology

Published: July 03, 2023

Novel urinary protein panels for the non-invasive diagnosis of non-alcoholic fatty liver disease and fibrosis stages.

Novel urinary protein panels for the non-invasive diagnosis of non-alcoholic fatty liver disease and fibrosis stages.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 25, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026